Prolonged survival in EGFR exon 20 insertion mutant lung adenocarcinoma: case report of sequential osimertinib and furmonertinib with research trend analysis
Sequential high-dose third-generation EGFR-TKIs may offer clinically meaningful benefit in selected EGFR ex20ins cases; however, this strategy remains non-standard and should be regarded as hypothesis-generating, warranting further prospective evaluation.
Authors
- Abdullah Al-Danakh
- Haijing Liu
- Ning Wang
- Yishan Lu
- Ruiguo Zhao
- Jingjing Zhao
- Ping Gao
- Nana Huang
Institutions
- Central South University (CN)
- Dalian Medical University (CN)
- Liaoning University of Traditional Chinese Medicine (CN)
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Xiangya Hospital Central South University (CN)
- Amran University (YE)
- Liaoning Cancer Hospital & Institute (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fmed.2025.1677737
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00